|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2006-1-19
|
|
pubmed:abstractText |
Glanzmann thrombasthenia is a rare, hereditary, congenital disorder of platelet function characterized by inappropriate bleeding that is difficult to control. Recombinant activated factor VII (rFVIIa) is a new treatment that is used to stop bleeding and provide surgical support for these patients. This report describes the use of rFVIIa to prevent serious bleeding during and after open-heart surgery in a child with Glanzmann thrombasthenia.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0172-0643
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
843-5
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:15690232-Blood Loss, Surgical,
pubmed-meshheading:15690232-Cardiac Surgical Procedures,
pubmed-meshheading:15690232-Child,
pubmed-meshheading:15690232-Coagulants,
pubmed-meshheading:15690232-Factor VII,
pubmed-meshheading:15690232-Factor VIIa,
pubmed-meshheading:15690232-Heart Defects, Congenital,
pubmed-meshheading:15690232-Humans,
pubmed-meshheading:15690232-Male,
pubmed-meshheading:15690232-Recombinant Proteins,
pubmed-meshheading:15690232-Thrombasthenia
|
|
pubmed:articleTitle |
Successful use of recombinant factor VIIa (NovoSeven) during cardiac surgery in a pediatric patient with Glanzmann thrombasthenia.
|
|
pubmed:affiliation |
Department of Pediatrics, Pediatric Hematology Unit, Baskent University Faculty of Medicine, 6.cad No:72/3 06490, Bahcelievler, Ankara, Turkey.
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
